• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » IBM, Rensselaer Polytechnic Institute to research chronic diseases with cognitive computing

IBM, Rensselaer Polytechnic Institute to research chronic diseases with cognitive computing

May 19, 2017
CenterWatch Staff

IBM and Rensselaer Polytechnic Institute announced the creation of the new Center for Health Empowerment by Analytics, Learning, and Semantics (HEALS). Located on the Rensselaer campus, the HEALS center is a five-year collaborative research effort aimed at researching how the application of advanced cognitive computing capabilities can help people to understand and improve their own health conditions.

"This collaboration between Rensselaer and IBM, which combines our significant research strengths in cognitive computing, could generate insights which will aid clinicians with more effective treatments for individual patients and overall efficiencies in the healthcare system," said Shirley Ann Jackson, president of Rensselaer. "In this expansion of our long-standing research partnership with IBM, I am pleased that HEALS will advance preventive healthcare."

"Cognitive computing is poised to transform every profession, industry, and economy, and IBM is committed to helping to solve the world's biggest health challenges," said Dr. John E. Kelly III, senior vice president, Cognitive Solutions and Research at IBM. "We are excited to collaborate with Rensselaer on the development of the HEALS research center to advance precision medicine with the help of Watson technologies and to help improve the quality of care clinicians can deliver to individuals."

The new center's vision is to advance the understanding of chronic disease prevention through data-driven discovery and analysis of factors that can help predict the propensity to develop chronic conditions and provide personalized health recommendations and lifestyle guidance for clinicians to deliver to their patients.

Specifically, the center plans to develop cognitive tools for health empowerment that use analytics, knowledge-driven learning, and semantics-based interrogation to address data-to-knowledge gaps to enable clinicians and patients to help manage and prevent of chronic diseases and conditions.

"We now have powerful computational and experimental tools that drive personalized health risk predictions. HEALS will exploit innovative capabilities in cognitive computing coupled with human behavior, smart device development, and semantic data analytics aimed at identifying patients at risk of chronic diseases for clinicians before the disease becomes difficult to treat," said Jonathan Dordick, vice president for research at Rensselaer. "This approach has the potential to revolutionize healthcare, reduce cost, and enhance the quality of life."

In addition to developing new computational technologies, RPI researchers at the HEALS center aim to collect relevant clinical and non-clinical knowledge, as well as gather and integrate user-generated data from such sources as individual lifestyle questionnaires, health or wellness data from mobile fitness tracking devices, and social network data from shared online activities.

The challenge lies in the personalized coupling of curated knowledge and individual data, according to James Hendler, director of the Rensselaer Institute for Data Exploration and Applications (IDEA) and the Tetherless World Professor of Computer, Web, and Cognitive Sciences at Rensselaer, who will serve as director of the HEALS center.

"IBM's Watson technology has made major inroads in life sciences and health," said Hendler. "Our goal now is to use Watson to help clinicians prevent people from developing chronic conditions by providing them with health information customized for their specific medical, environmental, and work/life situations. Doing this requires big data analytics, state-of-the art machine learning, and the technologies of the semantic web, allowing us to combine and process data from many different sources and use that information to help clinicians improve the quality of life for people who are at risk for diabetes, hypertension, and other chronic diseases."

The HEALS research center is part of IBM's Cognitive Horizons Network (CHN), a network of the world's leading universities committed to working with IBM to help accelerate the development of core technologies needed to advance the promise of cognitive computing. CHN members are dedicated to accelerating the application of AI and related technologies to some of the world's most enduring challenges, ranging from disease and the environment to transportation and education.

"Through the Cognitive Horizons Network, we are teaming with leading universities like RPI to explore and expand the societal impact of cognitive computing technology," said Henry Chang, program coordinator of HEALS, IBM Research. "The HEALS research center will study and work to advance the understanding of chronic condition identification in the pre-disease stage by identifying and analyzing actionable personal-risk determinants via a coupling of the knowledge of lifestyles risks and data-driven health causal and correlational factors."

Additional Rensselaer faculty involved in leading the center's research will include Deborah McGuinness, Tetherless World Senior Constellation Chair and professor of computer and cognitive sciences; Mohammed Zaki, professor of computer science; Bulent Yener, professor of computer science and director of the Data Science Research Center; Kristin Bennett, associate director of the IDEA and a professor in the mathematical sciences and computer science departments; and Jonathan Dordick, vice president for research and the Howard P. Isermann Professor of Chemical and Biological Engineering. The center will also include faculty from biology, engineering, social sciences, and management working together with IBM researchers to help change the way individuals approach their own healthcare. 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing